BioSpace News Archive

Jiffy Lube and the Muscular Dystrophy Association are teaming up for the ninth annual MUSCLE UP!℠ campaign.

The HealthWell Foundation®, an independent non-profit that provides a financial lifeline for inadequately insured Americans, has launched a new fund to provide copayment and premium assistance to Medicare patients living with B-Cell Lymphoma (BCL).

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced the publication of a manuscript in Nature Cancer1 that validates the ability of its Signatera™ personalized circulating tumor DNA (ctDNA) technology to evaluate tumor response to immunotherapy in 25 different types of solid cancer.

C Spire is teaming up with the Delta Regional Medical Center to debut a remote patient monitoring program in Mississippi for a broad array of chronic medical conditions that will help manage health care costs for hospitals in rural areas and improve the quality of life for patients.

Study will allow The Lundquist Institute to determine the multi-generational risks of developing asthma from vaping while pregnant

Study by CHOP sleep experts emphasizes the importance of screening for sleep problems at every age

Brickell Biotech, Inc., a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, announced that it will report its financial results for the second quarter ended June 30, 2020, after the market close on Wednesday, August 12, 2020.

Chiasma, Inc., a commercial stage biopharmaceutical company, announced that it will host a conference call and live audio webcast on Monday, August 10, 2020 at 5:00 p.m. Eastern Time to discuss financial results for the quarter ended June 30, 2020 and to provide a business update.

Data demonstrate potential “Best in Class” topical PDE4 inhibitor roflumilast significantly improves signs and symptoms of chronic plaque psoriasis

$125,000 grant seeks to further advance less invasive, more accurate testing for early disease detection and identification of peritoneal metastasis in gastric cancer